期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Integrated LOBS/GMPLS Network Testbed
1
作者 Wu Jian Hong Xiaobin +6 位作者 Guo Hongxiang Zhang Wenjia Liu Lei Takehiro Tsuritani tomohiro otani Masatoshi Suzuki Lin Jintong 《China Communications》 SCIE CSCD 2010年第3期11-23,共13页
In the context of dynamic telecommunication traffic requirement, experimental prototypes and testbeds have been vital and challenging steps towards achieving practical OBS networks. This paper presents the novel integ... In the context of dynamic telecommunication traffic requirement, experimental prototypes and testbeds have been vital and challenging steps towards achieving practical OBS networks. This paper presents the novel integrated LOBS/GMPLS network testbed. Dynamic interworking technologies between GMPLS network and LOBS network and potential survivability schemes in this multilayer network are investigated by experimentally evaluating the TCP and popular streaming media service performance over an integrated LOBS/ GMPLS testbed. 展开更多
关键词 LOBS GMPLS TESTBED
下载PDF
Tropifexor,a selective non-acid farnesoid X receptor agonist,improved nonalcoholic steatohepatitis in a phase 2 trial,but several issues remain to be resolved
2
作者 Masato Yoneda Takashi Kobayashi +4 位作者 Naohiro Wada tomohiro otani Asako Nogami Michihiro Iwaki Atsushi Nakajima 《Hepatobiliary Surgery and Nutrition》 SCIE 2023年第5期759-762,共4页
As obesity continues to escalate worldwide,nonalcoholic fatty liver disease(NAFLD)has emerged as the most prevalent form of liver disease,with a reported global prevalence of 30.1%(1).The prevalence of NAFLD,which was... As obesity continues to escalate worldwide,nonalcoholic fatty liver disease(NAFLD)has emerged as the most prevalent form of liver disease,with a reported global prevalence of 30.1%(1).The prevalence of NAFLD,which was around 25%in the 1990s,has been increasing year by year in recent years and has exceeded 35%in the past few years(1).The spectrum of disease includes nonalcoholic fatty liver(NAFL),characterized by macrovesicular hepatic steatosis that may be accompanied by mild inflammation,and nonalcoholic steatohepatitis(NASH),which is additionally characterized by the presence of inflammation and cellular injury(2). 展开更多
关键词 Nonalcoholic fatty liver disease(NAFLD) obesity nonalcoholic steatohepatitis(NASH) tropifexor selective non-acid farnesoid X receptor agonists(selective non-acid FXR agonists)
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部